Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
ENOV Q3 2026 deep dive: product innovation and share gains amid market volatility
Enovis Stock Earnings Beat Raises Full Year Outlook
What Enovis (ENOV) Said on Its Q3 Earnings Call
Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $42
Evercore ISI Group Maintains Outperform on Enovis, Raises Price Target to $33
Wells Fargo Maintains Overweight on Enovis, Raises Price Target to $37
Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript
Enovis Corporation 2026 Q3 - Results - Earnings Call Presentation
Enovis Corp (ENOV) Q3 2026 Earnings Call Highlights: Organic Growth of 5%, Raised Guidance, and ...
Enovis Corporation Q3 2026 Earnings Call Summary
Enovis Corp (ENOV) Q3 2026 Earnings Call Transcript
Needham Maintains Buy on Enovis, Raises Price Target to $38
Enovis Corporation Reports Third Quarter 2026 Results and Announces New $200 million Share Repurchase Authorization
BTIG Maintains Buy on Enovis, Raises Price Target to $42
Enovis’s (NYSE:ENOV) Q3 2026 earnings results: revenue in line with expectations, stock soars
Enovis: Q3 Earnings Snapshot
ENOVIS Announces Third Quarter 2026 Results
Enovis Q3 2026 Earnings Call Transcript
Enovis Q3 Adj. EPS $0.88 Beats $0.77 Estimate, Sales $558.725M Beat $557.010M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.